AlphanoxLtd Past Earnings Performance

Past criteria checks 0/6

AlphanoxLtd's earnings have been declining at an average annual rate of -12.4%, while the Medical Equipment industry saw earnings growing at 19.3% annually. Revenues have been growing at an average rate of 5.1% per year.

Key information

-12.4%

Earnings growth rate

-7.2%

EPS growth rate

Medical Equipment Industry Growth	22.7%
Revenue growth rate	5.1%
Return on equity	-95.5%
Net Margin	-70.6%
Last Earnings Update	30 Sep 2024

Recent past performance updates

Recent updates

Alphanox Co.,Ltd. (KOSDAQ:043100) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Dec 05

Investors Don't See Light At End Of Alphanox Co.,Ltd.'s (KOSDAQ:043100) Tunnel And Push Stock Down 27%

Sep 30

Is Solco Biomedical (KOSDAQ:043100) Using Debt In A Risky Way?

Jun 27

Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) 27% Dip In Price Shows Sentiment Is Matching Revenues

Jun 27

Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

Feb 27

Revenue & Expenses Breakdown

How AlphanoxLtd makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A043100 Revenue, expenses and earnings (KRW Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
30 Sep 24	27,356	-19,316	15,763	2,191
30 Jun 24	27,314	-18,896	16,083	2,325
31 Mar 24	27,721	-18,326	16,173	2,460
31 Dec 23	26,878	-19,966	16,292	2,263
30 Sep 23	25,504	-11,733	13,937	2,285
30 Jun 23	24,869	-11,049	12,112	2,356
31 Mar 23	23,869	-10,519	11,544	2,110
31 Dec 22	23,396	-9,528	10,617	1,923
30 Sep 22	23,974	-6,299	11,826	1,652
30 Jun 22	23,501	-5,836	12,578	1,535
31 Mar 22	23,769	-4,983	11,950	1,350
31 Dec 21	23,951	-4,075	11,498	1,408
30 Sep 21	23,798	-175	7,995	1,214
30 Jun 21	24,316	-530	7,403	1,155
31 Mar 21	23,209	1,188	5,444	1,188
31 Dec 20	22,854	1,647	5,442	1,018
30 Sep 20	21,555	-11,256	9,002	1,008
30 Jun 20	21,158	-11,587	9,274	833
31 Mar 20	21,756	-16,841	14,504	824
31 Dec 19	21,442	-18,764	15,501	955
30 Sep 19	21,333	-16,920	17,551	1,081
30 Jun 19	22,344	-17,837	18,906	888
31 Mar 19	22,222	-15,641	16,360	980
31 Dec 18	22,541	-15,350	15,961	1,187
30 Sep 18	23,551	-6,445	11,504	1,037
30 Jun 18	23,007	-7,231	11,305	1,037
31 Mar 18	23,822	-7,613	10,964	1,336
31 Dec 17	23,211	-8,528	10,510	1,780
30 Sep 17	22,857	-9,593	11,325	2,305
30 Jun 17	22,554	-9,058	11,435	2,305
31 Mar 17	22,204	-8,935	11,269	2,207
31 Dec 16	23,722	-7,983	10,875	2,083
30 Sep 16	24,189	-8,432	11,970	1,722
30 Jun 16	24,174	-8,403	11,584	1,722
31 Mar 16	22,986	-7,838	11,830	1,477
31 Dec 15	22,432	-7,006	11,040	1,004
30 Sep 15	25,154	-1,094	7,309	1,116
30 Jun 15	25,063	-2,227	7,664	1,116
31 Mar 15	27,940	-1,782	12,521	871
31 Dec 14	30,141	-2,175	13,488	871
30 Sep 14	31,154	-7,426	15,703	734
30 Jun 14	33,051	-5,588	16,262	734
31 Mar 14	34,506	-5,474	11,354	820

Quality Earnings: A043100 is currently unprofitable.

Growing Profit Margin: A043100 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A043100 is unprofitable, and losses have increased over the past 5 years at a rate of 12.4% per year.

Accelerating Growth: Unable to compare A043100's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A043100 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-13.3%).

Return on Equity

High ROE: A043100 has a negative Return on Equity (-95.45%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/26 04:04
End of Day Share Price	2025/01/24 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Alphanox Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution